Automotive Industry Turbulence Continues to Hurt Jenoptik; Company Profits Down for Quarter - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Automotive Industry Turbulence Continues to Hurt Jenoptik; Company Profits Down for Quarter

    Article obtained from Photonics RSS Feed.

    Jenoptik profits declined for the quarter, with the company reporting revenue of just over €176 million for the period ending Sept. 30, and €505 million for the nine-month period ending on the same date. The figures represent decreases of more than 17% and 15%, respectively, from the close of the previous year’s third quarter. Quarterly earnings per share (EPS) fell year over year, from 35 cents (€) to 24 cents (31%), and from 77 cents to 43 cents (45%) year over year for the first nine months of the year.

    Revenue for the quarter was up sequentially, by 6.9%, Jenoptik reported. Due to acquisitions, the company said in its quarterly earnings report published Nov. 10, order intake reached the previous year’s…

    READ MORE
    Nov, 10 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.